GH1 and metabolic dysfunction-associated steatotic liver disease: GH and its signaling pathway, acting mainly through insulin-like growth factor-I (IGF-I), regulate lipid metabolism in the liver (219) and play an important role in antagonizing NAFLD, by directly reducing DNL in the hepatocytes and by inactivating HSCs, therefore limiting fibrosis (220).